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The analysis ofmicronuclei (MN) incultured human lymphocytes is, in principle, able to detectexposureto
clastogens and aneuploidogens alike. There is, however, no clear evidence from human biomonitoring studies
or animal experiments showing that in vivo exposure of resting lymphocytes to an aneuploidogen could
actuallybe expressed as MN in cultured lymphocytes. In vitro, apulse treatment ofhuman lymphocytes with
vinblastine, an aneuploidogen, did result in MN induction even if performed before mitogen stimulation,
although a much more pronounced effect was obtained in activelydividinglymphocyte cultures. On the other
hand, it is probable that a considerable portion of "spontaneous" MN contain whole chromosomes, their
contribution increasing with age. It also seems that cytochalasin B, used for the identification ofsecond cell
cycle interphase cells in the MN assay, is able toslightly increase the level ofMNwith whole chromosomes. If
MN harboring chromosome fragments represent a minority of the total MN frequency, there may be
difficulties in detecting a weak effect in this fraction of MN against the background of MN with whole
chromosomes. This would reduce the sensitivity ofthe assay in detecting clastogens, unless MN with whole
chromosomes and chromosome fragments are distinguished from each other. That a problem may exist in
sensitivity is suggested by the difficulty in demonstrating MN induction by smoking, an exposure capable of
inducingchromosomeaberrations.Thesensitivityofthelymphocyte MNassaycouldbeincreasedbydetecting
kinetochore or centromere in MN, or by automation, allowing more cells to be analyzed.
Introduction
The analysis of micronuclei (MN) in cultured lympho-
cytes is increasingly applied as a method to biomonitor
human exposure to genotoxic agents, largely because the
cytokinesis block (CB) technique (1) has made it possible
to identify cells that have divided once in culture (second
cycle interphase cells). Most ofthe MN resulting from in
vivo exposure to a genotoxin are formed from preexisting
lesions when the stimulated lymphocytes divide for the
first time in vitro.
This paper discusses the applicability ofthe MN assay
forbiomonitoring human exposure to genotoxins. The key
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questions inthis respect arethe sensitivityofthe assayin
detecting exposure to clastogens andaneuploidogens, fac-
tors modifying the background level of MN, and the
possible influence ofcytochalasin B (Cyt-B) used to pro-
duce the CB.
Is Exposure to Aneuploidogens
Detected?
Ithasconvincinglybeenshowninexperimental animals
that both clastogens and aneuploidogens are able to pro-
duce MN in actively dividing tissues (2). Aneuploidogens
also induce MN in human lymphocytes when the treat-
ment occurs after mitogen stimulation (3). Although
aneuploidogens such as spindle poisons preferentially
affect actively dividing cells, exposure ofresting lympho-
cytes (most peripheral lymphocytes are in Go stage in
vivo) might also be expected to induce MN in stimulated
lymphocytes if a) the aneuploidogens act upon the G.
precursorsofthemitoticapparatus, b)theconcentrationof
the aneuploidogen present in the blood sample is high
enough atthe time ofthe first in vitro divisions, orc) MN
generated bythe exposure in vivo arefrequentenough toNORPPA ET AL.
be detected against the high background of MN induced
"spontaneously" at the first in vitro divisions.
Investigations on human exposure to pure aneu-
ploidogens are rare. Two studies describing MN assays
after occupational exposure to mercury compounds,
known to be aneuploidogenic, have, however, been pub-
lished. One study ofchloroalkali workers exposed to mer-
curyvapor (4), showing correlation ofMN frequencywith
cumulative exposure index and with the number ofblood
mercury peaks, was difficult to interpret because Cyt-B
was not employed. The other study, which used the CB
method and described increased MN frequencies among
explosives workers exposed to mercury fulminate, might
have reflected clastogenic exposure as well because the
workers also had elevated levels of chromosome aberra-
tions (5).
A simple way to study the question ofwhether MN can
be induced by aneuploidogen exposure ofresting lympho-
cytesistotreatlymphocyteswithananeuploidogenbefore
mitogen stimulation. Results fromthis kind ofexperiment
withvinblastine sulfate are shown in Figure 1. MN induc-
tionwas observed with all ofthe treatment schedules, but
there were enormous differences in the response. Treat-
ments started when plytohemagglutinin (PHA) had been
present for 24 hr and continued for 72 or 48 hr until cell
harvest, providing good possibilities for the drug to inter-
act with dividing cells. This treatment resulted in an
efficient induction of MN at such low concentrations of
vinblastine as 1 or2.5ng/mL,respectively,whereasa24-hr
pulse treatment between 24 and 48 hr (with less mitoses
available) of 72-hr cultures required 40 ng/mL of vin-
blastine for a positive response. It is also evident from
8.0
7.0
6.0
o 6.
4.0
E
3.0
o 2.0
1.0
I0
0.6 2.6
1 10
Vlnblastine concentration (nlgmi)
26 4060 g0
100
FIGURE 1. Effect of vinblastine sulfate on micronucleated binucleate
lymphocytes in whole-blood cultures of two male blood donors. The
symbols represent means; error bars show individual results from the
two donors. (-) 72-hr treatment from hour 24 ofculture until harvest;
(A) 48-hr treatment from hour 24 of culture until harvest; (0) 24-hr
pulse treatment between hour 24 and 48 of a 72-hr culture; (0) 24-hr
pulse treatment without phytohemagglutinin (PHA; present in other
cultures from the start), followed by 72-hr incubation with PHA. At the
end of the 24-hr pulse treatment, the cells were washed twice with
phosphate-buffered saline. Cytochalasin B was added at 44 hr (in the
pulse treatment ofstimulated lymphocytes at 48 hr) after culture initia-
tion orPHAaddition;1000cells werescored pertreatmentfromair-dried
May-Griinwald-Giemsa-stained slides.
Figure 1 that the 24-hr pulse treatment of nondividing
cells, performed before mitogen stimulation, was the least
effective, yielding a positive result (a 3.7-fold elevation
above the control level) only at the highest concentration
available foranalysis (100ng/mL; 250ng/mLwastoxic). It
was not possible to tell whether this response was due to
an effect induced in the resting stage and retained until
mitosis or to residual vinblastine left in the cells or in the
culturemedium, despitethewash. Nevertheless, elevation
oflymphocyte MN levels in a human biomonitoring study
cannotbeexpectedtoresultfrominvivoexposuretosome
unestablished orunknownaneuploidogenic agentbeforeit
has been shown experimentally or by human studies that
aninvivoaneuploidogen exposureis abletoinfluenceMN
levels in cultured lymphocytes.
Is Exposure to Clastogens Detected?
Studies on patients exposed to ionizing radiation and
chemotherapyhaveclearlyshownthataninvivoexposure
to clastogens can result in MN induction in stimulated
bloodlymphocytes (6-10). Experiencewithlowerexposure
levels such as encountered in occupational chemical expo-
sure has been less encouraging.
Since the firsthuman biomonitoring study (11,12) using
Cyt-B-which did show elevated MN levels among cyclo-
phosphamide process workers and oncology nurses
exposedtocytostatics-biomonitoring studieswith aposi-
tive MN outcome from exposures to chemical genotoxins
(other than cytostatics in cancertherapy) have been rare.
In Finland, investigations of exposure to styrene in the
reinforced plastics industry (13,14), power-line workers
exposed to electric and magnetic fields (15), and formal-
dehyde-exposedindustryworkers(Table1)haveallyielded a
negative outcome for MN. A tentative positive finding was
recorded in one study comparing lymphocyte MN levels
among hospital pharmacists before and after 1 year of
handlingofcytostatics, althoughthedifferencetoamatched
control group was not significant (Table 1). Biomonitoring
studies from othercountries havefound no deviationfrom
control MN frequencies in tanneryworkers (16), ethylene
oxide-exposed sanitary workers (17), and human volun-
teers taking the clastogenic analgesic paracetamol (18).
With so few studies available, the negative outcomes
could reflect the fact that the exposures studied were not
the best choices for evaluating the lymphocyte MN assay.
Nevertheless, in several of the investigations mentioned
above(15-18), someotherparameterofgenotoxicexposure
(e.g. MN in buccal mucosa in our study offormaldehyde
exposure; data not published) gave positive results.
Another exposure, which usuallyproduces elevations in
chromosome aberrations and sister chromatid exchanges,
butnotinMN,issmoking(4,5,11-13,16).Auetal.(19)found
a slight but nonsignificant elevation of MN among
smokers. Although Tomanin etal. (20) were able to show a
statistically significant difference in MN levels between
smokers and nonsmokers, the overall impression that one
gets from the few studies available is that the CB MN
assaydoesnotdetectsmokingasefficientlyastheanalysis
ofchromosome aberrations does.
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Table 1. Micronuclei (MN) in binucleated lymphocytes in whole-blood cultures offormaldehyde-exposed workers (plywood, fiberglass, and
impregnation plants) and hospital pharmacists exposed to cytostatics.a
Mean % (SD)
Studied group No. ofsubjects No. ofmen No. ofsmokers Mean age, years cells with MN
Formaldehyde exposed 22 16 6 40 2.5 (0.8)
Controls 22 16 6 40 3.0 (1.0)
Pharmacists
1990 7 0 0 39 3.0 (1.1)
1991 7 0 0 40 3.7 (1.0)*
Controls
1990 7 0 0 39 3.0 (0.2)
1991 7 0 0 40 3.3 (0.8)
aFormaldehyde-exposed workers: 1000 cells scored/person, acridine orange staining; hospital pharmacists: 500 cells scored/sample, May-
Griinwald-Giemsa staining. Both studies had a control group matched for sex, age, and smoking habits. For hospital phamacists, sampling was
performed before and after 1 year ofexposure.
*p < 0.05,1991 versus 1990 (two-tailed t-test for paired observations).
A very interesting finding in this context is that of
Larramendy and Knuutila (21), which suggests that some
immunologicallyclassified subsets ofculturedhumanlym-
phocytes, such as pan B cells (CD20+CD22) and,
especially, suppressor/cytotoxic T8 lymphocytes (CD8)
are more sensitive than others to MN induction by smok-
ing. For the T8 lymphocytes the difference between
smokers and nonsmokers in MNlevelswas almost15-fold.
Cyt-Bwas notusedinthe MN evaluation, buttheanalysis
of mitotic indices (at 72 hr) indicated no differences in
mitotic activity between smokers and nonsmokers.
Micronuclel Containing Whole
Chromosomes: Effect of Age and
Cytochalasin B
Several studies (4,6,8,11,12,14,16,19) have demonstrated
that age affects the MN frequency of cultured human
lymphocytes, the effect being steeper for women than for
men. Lymphocyte MN appear to contain whole chromo-
somes more often among the elderly (>65 years) than
among young people (20-35 years), as indicated by the
frequency ofMN staining positivelywith antikinetochore
antibodies (50% and 42%, respectively), although some
age-related MN might harbor whole chromosomes with
inactivated centromeres and lack kinetochore staining
(6,22).
Ourunpublished findings with cultured lymphocytes of
three male subjects (aged 32-39 years) indicate that the
majority of MN contain a centromere and that MN are
more frequently kinetochore positive in Cyt-B-induced (3
,ug/mL) binucleate cells (mean 84%) than inmononucleate
cells of cultures not containing Cyt-B (mean 63%). This
would suggestthatCyt-Binduces MNwithwholechromo-
somes.
Infact, it has quite conclusively been shown thatCyt-B
induces MN in human lymphocytes (23). High MN fre-
quencies are, however, restricted to multinucleate (cells
withmorethan twonuclei)lymphocytes,which areformed
when the binucleate cells further divide. The MN are
probably the result of disorganized multipolar divisions
and, because multipolar anaphases in Cyt-B-treated
human lymphocyte cultures have a high level of lagging
chromosomes, contain whole chromosomes (23).
The important question is, ofcourse, does Cyt-B affect
MN in binucleate cells. Fenech and Morley (1) reported
that there was no difference in MN frequencies between
binucleate cellsproducedbyCyt-B andmononucleatecells
not treated with Cyt-B. In accordance with the results of
Prosser et al. (24), we observed no dose response in MN
frequencies in binucleate cells at different concentrations
of Cyt-B (23). On the other hand, we found no dose
dependency for MN inmultinucleate cells either, although
theycontained some 9-21 times higherbasic MNfrequen-
cies than the binucleate cells. Dose response may not be
expected when the analysis is restricted to cells that are
identified as beingaffected (i.e.,multinucleated orbinucle-
ated) by Cyt-B.
Ourexperiments didsuggestadose-dependentincrease
inlaggingchromosomes, althoughonlytheregressionwas
significant, in bipolar anaphases ofCyt-B-treated human
lymphocyte cultures (Table 2). As it is known that a
decreasing portion ofdividing cells are able to escape the
CB with increasing concentrations ofCyt-B (25), the dose
responsecouldbeexplainedifoneassumesthatthebipolar
divisions committed to become binucleated have an
increased tendency to developlaggingchromatids. Table 2
mayalsosuggestaninfluenceofCyt-B onthefrequencyof
anaphase bridges, although there is no dependency on
Cyt-B concentration.
It is not yet clear what percentage of the MN seen in
binucleated cells is due to Cyt-B, although the possible
effect cannot be nearly as dramatic as seen in multinucle-
ate cells produced by Cyt-B. In any case, unless
kinetochores (2,3,22,26) or centromeres (27,28) (Fig. 2) in
MN arelabeled, there maybe difficulties indetectingeven
adoublinginMNharboringchromosomefragmentsagainst
the background ofMNwithwhole chromosomes,which are
uninformative with respect to clastogenic exposure.
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Table 2. Effect ofa 28-hr treatment (from hour 44 until harvest) with cytochalasin B (Cyt-B) on the frequency of
bipolar anaphases with aberrations.a
Cyt-B concentration, Anaphases with aberrations, mean % (SD)
,ug/mL No. ofanaphases studied Lagging chromatin* Bridges Total
0 587 1.5 (1.5) 0.3 (0.3) 1.9 (1.8)
1.5 532 2.2 (1.0) 1.5 (1.3)t 3.2 (1.8)
3.0 142 2.9 (1.3) 0.7 (1.3) 2.9 (1.3)
6.0 78 3.4 (3.4) 0.0 (0.0) 4.5 (5.1)b
12.0 92 4.2 (0.6) 1.3 (2.3) 4.2 (0.6)
aMeans from the isolated lymphocyte cultures ofthree male donors and standard deviations are shown (26).
bOne anaphase with a disrupted pole included.
*Linear regression significant (p < 0.01, two-tailed t-test); r = 0.95.
tp < 0.05, Fisher's exact probability test (1-tailed).
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FIGURE 2. A binucleated human lymphocyte with a micronucleus show-
ing a centromeric signal. In situ hybridization of the aiphoid DNA
oligomer probe SO ciAliCen (28) with the sequence GTTTTGAAACiO-
ACTCTTTTTG2OTAGAATCTGC3O; digoxigenin label and immuno-
peroxidase/diaminobenzidine detection; counterstaining with Wright's
stain.
Improving the Sensitivity of Human
Lymphocyte Micronucleus Assay
It is obvious that the sensitivity of the MN assay in
monitoring human exposure to genotoxins could be
increased in several different ways. In revealing the spe-
cific effects ofclastogens, considerable improvement could
be achieved byincluding onlythose MN that do nothave a
kinetochore or a centromere (3,22,26). Ifin vivo exposure
to aneuploidogens turns out to be detectable by the MN
assay, thesametechniques couldbeusedtodistinguish the
influence ofboththe clastogenic and aneuploidogenic com-
ponents of an in vivo exposure. Kinetochore/centromere
detectionwould alsoremove thepossible problem ofCyt-B
inducing MN harboringwhole chromosomes. Onthe other
hand, the CBmethod couldbereplacedbyotherassaysfor
identifying second cycle interphases. We have developed
one such alternative, based on the use of pulse labeling
with 5-bromodeoxyuridine followed by label detection by
antibromodeoxyuridine antibody (29). If T8 lymphocytes
really are much more sensitive to smoking-induced MN
than other lymphocyte subpopulations (21), MN analysis
could possibly be restricted to these lymphocytes alone
also in other exposures.
Finally, as the resolution of the analysis of such rela-
tively rare events as MN could be enhanced byincreasing
the number ofcells scored per sample, the development of
automated approaches to MN analysis would also much
improve the sensitivity ofthe assay (2).
This work was supported by the Finnish Work Environment Fund
(Project 89266), and CEC contract no. EV4V-0213-FI. Luigina Renzi's
visit in Finland was supported by the Finnish Ministry ofEducation.
REFERENCES
1. Fenech, M., and Morley, A.A. Measurement ofmicronuclei inlympho-
cytes. Mutat. Res. 147: 29-36 (1985).
2. Heddle, J. A., Cimino, M. C., Hayashi, M, Romagna, F., Shelby, M. D.,
Thcker, J. D., Vanparys, Ph, and MacGregor, J. T. Micronuclei as an
index ofcytogenetic damage: past, present, andfuture. Environ. Mol.
Mutagen. 18: 277-291 ( 1991).
3. Eastmond, D. A., and Thcker, J. D. Identification of aneuploidy-
inducing agents using cytokinesis-blocked human lymphocytes and
an antikinetochore antibody. Environ. Mol. Mutagen. 13: 34-43
(1989).
4. Barregard, L., H6gstedt, B., Schiitz, A., Karlsson, A., Saillsten, G.,
Thiringer, G. Effects of occupational exposure to mercury vapor on
lymphocyte micronuclei. Scand. J. Work Environ. Health 17: 263-268
(1991).
5. Anwar, W. A., andGabal, M. S. Cytogenetic studyinworkers occupa-
tionally exposed to mercury fulminate. Mutagenesis 6: 189-192
(1991).
6. Fenech,M.Optimisation ofmicronucleus assaysforbiologicaldosime-
try. In: New Horizons in Biological Dosimetry (B. L. Gledhill and F.
Mauro, Eds.), Wiley-Liss, New York, 1991, pp. 373-386.
7. Fenech, M, Denham, J., Francis, W., and Morley, A. Micronuclei in
cytokinesis-blocked lymphocytes of cancer patients following frac-
tionated partial-body radiotherapy. Int. J. Radiat. Biol. 57: 373-383
(1990).
8. Migliore, L., Guidotti, P., Favre, C., Nardi, M., Sessa, M. R., and
Brunori, E. Micronuclei in lymphocytes of young patients under
antileukemic therapy. Mutat. Res. 263: 243-248 (1991).
9. Sarto, F., Tomanin, R., Giancomelli, L., Canova, A., Raimondi, F.,
Ghiotto, C., and Fiorentino, M.V. Evaluation ofchromosomal aberra-
tionsinlymphocytes andmicronucleiinlymphocytes,oralmucosaand
hair root cells ofpatients under antiblastic therapy. Mutat. Res. 228:
157-169 (1990).
10. Sinies, B., Nuniez, E., Bernal, M. L., Alcala, A., Saenz, M. A., and
Conde, B. Micronucleus assay in biomonitoring of patients under-
going excretory urography with diatrizoate and ioxaglate. Mutat.
Res. 260: 337-342 (1991).
11. Yager, J. W., Sorsa, M., Selvin, S. Micronuclei in cytokinesis-blocked
lymphocytes as an index of occupational exposure to alkylating
cytostatic drugs. In: Methods for Detecting DNADamagingAgents
in Humans: Applications in Cancer Epidemiology and Prevention (H.
Bartsch, K. Hemminki, and I. K. O'Neill, Eds.), IARC ScientificMICRONUCLEUS ASSAY 143
Publication No. 89, International Agency for Research on Cancer,
Lyon, 1988, pp. 213-216.
12. Sorsa, M., Pyy, L., Salomaa, S., Nylund, L., andYager,Y.W. Biological
and environmental monitoring of occupational exposure to
cyclophosphamide in industry and hospitals. Mutat. Res. 204: 465-
479 (1988).
13. Maki-Paakkanen, J., Walles, S., Osterman-Golkar, S., and Norppa, H.
Single-strand breaks, chromosome aberrations, sister chromatid
exchanges, and micronuclei inblood lymphocytes ofworkers exposed
to styrene duringtheproduction ofreinforced plastics. Environ. Mol.
Mutagen. 17: 27-31 (1991).
14. Sorsa, M., Anttila, A., Jarventaus, H., Kubiak, R., Norppa, H.,
Nylander, L., Pekari, K., Pfaffli, P., andVainio, H. Styrene revisited-
exposure assessment andriskestimation inreinforcedplastics indus-
try. In: New Horizons in Biological Dosimetry (B. L. Gledhill, and F.
Mauro, Eds.), Wiley-Liss, New York, 1991, pp. 187-195.
15. Paile, W., Salomaa, S., Jokela, K., Koivistoinen, A., Norppa, H., Sorsa,
M.,Jirventaus, H.,Valjus, J., Jirvinen, P., and Kajander, J. Cytogene-
tic effects of50-Hz EM fields-occupational and in vitro studies. In:
Abstracts oftheThirteenth Annual MeetingoftheBioelectromagne-
tics Society, Salt Lake City, Utah, June 23-27, 1991.
16. Migliore, L., Parrini, M., Sbrana, I., Biagini, C., Battaglia, A., and
Loprieno, N. Micronucleated lymphocytes in people occupationally
exposed to potential environmental contaminants: the age effect.
Mutat. Res. 256: 13-20 (1991).
17. Sarto, F., T6rnqvist, M. A., Tomanin, R., Bartolucci, G. B., Osterman-
Golkar, S. M., and Ehrenberg, L. Studies ofbiological and chemical
monitoring of low-level exposure to ethylene oxide. Scand. J. Work
Environ. Health 17: 60-64 (1991).
18. Kocisova, J., and gram, R. J. Mutagenicity studies on paracetamol in
human volunteers III. Cytokinesis block micronucleus method.
Mutat. Res. 244: 27-30 (1990).
19. Au, W. W.,Walker, D. M., Ward, J. B., Jr., Whorton, E., Legator, M. S.,
Singh, V. Factors contributing to chromosome damage in lympho-
cytes ofcigarette smokers. Mutat. Res. 260: 137-144 (1991).
20. Tomanin, R., Ballarin, C., Nardini, B., Mastrangelo, G., and Sarto, F.
Influence ofsmoking habit on the frequency ofmicronuclei in human
lymphocytes by the cytokinesis block method. Mutagenesis 6: 123-
126 (1991).
21. Larramendy, M. L., and Knuutila, S. Increased frequency of micro-
nuclei in B and T8 lymphocytes from smokers. Mutat. Res. 259: 189-
195 (1991).
22. Fenech, M., and Morley,A.A. Kinetochoredetectioninmicronuclei: an
alternative method for measuring chromosome loss. Mutagenesis 4:
98-104 (1989).
23. Lindholm, C., Norppa, H., Hayashi, M., and Sorsa, M. Induction of
micronuclei and anaphase aberrations by cytochalasin B in human
lymphocyte cultures. Mutat. Res. 260: 369-375 (1991).
24. Prosser, J. S., Moquet, J. E., Lloyd, D. C., and Edwards, A. A.
Radiationinduction ofmicronucleiinhumanlymphocytes. Mutat. Res.
199: 37-45 (1988).
25. Littlefield, L. G., Sayer, A. M., and Frome, E. L. Comparison ofdose-
response parameters for radiation-induced acentric fragments and
micronuclei observed in cytokinesis-arrested lymphocytes. Muta-
genesis 4: 265-270 (1989).
26. Thomson, E. J., and Perry, P. E. The identification ofmicronucleated
chromosomes: a possible assay for aneuploidy. Mutagenesis 3: 415-
418 (1988).
27. Becker, P., Scherthan, H., and Zanki, H. Use ofa centromere-specific
DNA probe (P82H) in nonisotopic in situ hybridization for classifica-
tion ofmicronuclei. Genes Chrom. Cancer 2: 59-62 (1990).
28. Meyne, J., Littlefield, L. G., and Moyzis, R. K. Labeling of human
centromeres using an alphoid DNA consensus sequence: application
to the scoring of chromosome aberrations. Mutat. Res. 226: 75-79
(1989).
29. Autio, K., Norppa, H., Hayashi,M.,Miiki-Paakkanen, J., and Sorsa, M.
Human lymphocyte micronucleus assay using antibromodeox-
yuridine antibody instead ofcytochalasin. Mutat. Res. 252: 217-218
(1991).